Effects of cocaine on c-Fos and NGFI-B mRNA expression in transgenic mice underexpressing glucocorticoid receptors

Neuropsychopharmacology

Volumn 28, Issue 3, 2003, Pages 478-489

  St Hilaire, M ^a   Tremblay, P O ^a   Levesque D ^a,b   Barden, N ^a,b   Rouillard, C ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Glucocorticoids; In situ hybridization; Nuclear receptors; Transcription factors; Transgenic mice

Indexed keywords

CELL RECEPTOR; COCAINE; DNA BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; NUCLEAR RECEPTOR NUR77; STEROID RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MOUSE; ONCOGENE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; COCAINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, FOS; HUMANS; MALE; MICE; MICE, TRANSGENIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, STEROID; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0038690575     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300067     Document Type: Article

References (54)

1. Andrews CM, Lucki I (2001). Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology 155: 221-229.
2. Badiani A, Browman KE, Robinson TE (1995). Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res 674: 291-298.
3. Barden N, Stec IS, Montkowski A, Holsboer F, Reul JM (1997). Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the gluco-corticoid receptor. Neuroendocrinology 66: 212-220.
4. Barrot M, Marinelli M, Abrous DN, Rouge-Pont F, Le Moal M, Piazza PV (2000). The dopaminergic hyper-responsiveness of the shell of the nucleus accumbens is hormone-dependent. Eur J Neurosci 12: 973-979.
5. Beaudry G, Langlois M-C, Weppe I, Rouillard C, Levesque D (2000).Contrasting patterns and cellular specificity of transcrip-tional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J Neurochem 75: 1694-1702.
6. Beaulieu S, Rousse I, Gratton A, Barden N, Rochford J (1994). Behavioral and endocrine impact of impaired type II glucocor-ticoid receptor function in a transgenic mouse model. Ann NY AcadSci 746: 388-391.
7. Chen N-H, Reith MEA (1994). Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J Neurochem 63: 1701-1713.
8. Clement JG, Mills P, Brockway B (1989).Use of telemetry to record body temperature and activity in mice. J Parmacol Meth 21: 129-140.
9. Cyr M, Morissette M, Barden N, Beaulieu S, Rochford J, Di Paolo T (2001). Dopaminergic activity in transgenic mice underexpres-sing glucocorticoid receptors: effect of antidepressants. Neu-roscience 102: 151-158.
10. Das S, Grunert M, Williams L, Vincent SR (1997). NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture. Synapse 25: 227-233.
11. Drago J, Gerfen CR, Westphal H, Steiner H (1996). D1 dopamine receptor-deficient mouse: cocaine-induced regulation of im-mediate-early gene and substance P expression in the striatum. Neuroscience 74: 813-823.
12. Farisse J, Hery F, Barden N, Hery M, Boulenguez P (2000). Central 5-HT1 and 5-HT2 binding sites in transgenic mice with reduced glucocorticoid receptor number. Brain Res 862: 145-153.
13. Franklin TR, Druhan JP (2000).Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocaine-paired environment. Eur J Neurosci 12: 2097-2106.
14. Gervais J, Soghomonian JJ, Richard D, Rouillard C (1999). Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum. Neuroscience 91: 1045-1054.
15. Hagerty T, Fernandez E, Lynch K, Wang S-S, Morgan WW, Strong R (2001a). Interaction of a glucocorticoid-responsive element with regulatory sequences in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 78: 1379-1388.
16. Hagerty T, Morgan WW, Elango N, Strong R (2001b). Identifica-tion of a glucocorticoid-responsive element in the promoter region of the mouse tyrosine hydroxylase gene. J Neurochem 76: 825-834.
17. Haile CN, GrandPre T, Kosten TA (2001). Chronic unpredictable stress, but not chronic predictable stress, enhances the sensitivity to the behavioral effects of cocaine in rats. Psychopharmacology 154: 213-220.
18. Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstrom AC et al (1986). Glucocorticoid receptor immunoreactivity in mono-aminergic neurons of rat brain. ProcNatlAcadSci USA 83: 9779-9783.
19. Hiroi N, Brown JR, Haile CN, Ye H, Greenberg ME, Nestler EJ (1997). FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine’s psychomotor and rewarding effects. ProcNatlAcadSci USA 94: 10397-10402.
20. Hooks MS, Jones GH, Smith AD, Neill DB, Justice JB (1991). Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse 9: 121-128.
21. Hope B, Kosofsky B, Hyman SE, Nestler EJ (1992). Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. ProcNatlAcadSci USA 89: 5764-5768.
22. Hope B, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y et al (1994). Induction of a long lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron13: 1235-1244.
23. Hyman SE, Malenka RC (2001). Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695-703.
24. Kabbaj M, Devine DP, Savage VR, Akil H (2000). Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 20: 6983-6988.
25. Langlois M-C, Beaudry G, Rouillard C, Levesque D (2001). Impact of neuroleptic administration on coordinate expression of nuclear receptors in the cortex and striatal complex of the rat brain. Neuroscience 106: 117-128.
26. Linthorst ACE, Flachskamm C, Barden N, Holsboer F, Reul JM (2000). Glucocorticoid receptor impairment alters CNS re-sponses to a psychological stressor: an in vivo microdialysis study in transgenic mice. Eur J Neurosci12: 283-291.
27. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF (2000). Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20: 798-805.
28. Nestler EJ (2001).Molecular basis of long-term plasticity under-lying addiction. Nat Rev Neurosci 2: 119-128.
29. Partridge B, Schenk S (1999).Context-independent sensitization to the locomotor-activating effects of cocaine. PharmacolBiochem Behav 63: 543-548.
30. Pepin MC, Pothier F, Barden N (1992). Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355: 725-728.
31. Piazza PV, Barrot M, Rougee-Pont F, Marinelli M, Maccari S, Abrous DN et al (1996a). Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. ProcNatlAcadSci USA 93: 15445-15450.
32. Piazza PV, Rougee-Pont F, Deroche V, Maccari S, Simon H, Le Moal M (1996b). Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc NatlAcadSci USA 93: 8716-8720.
33. Piazza PV, Deminiere JM, Le Moal M, Simon H (1989).Factors that predict individual vulnerability to amphetamine self-adminis-tration. Science 245: 1511-1513.
34. Piazza PV, Le Moal M (1998).The role of stress in drug self-administration. Trends PharmacolSci 19: 67-74.
35. Ritz MC, Boja JW, Grigoriadis D, Zaczek R, Carroll FI, Lewis AH et al (1990a). [3H]WIN 35,065-2: a ligand for cocaine receptors in striatum. J Neurochem 55: 1556-1562.
36. Ritz MC, Cone EJ, Kuhar MJ (1990b). Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci 46: 635-645.
37. Rochford J, Beaulieu S, Rousse I, Glowa JR, Barden N (1997). Behavioral reactivity to aversive stimuli in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: effects of diazepam and FG-7142.Psychopharmacology 132: 145-152.
38. Sapolsky RM, Armanini MP, Packan DR, Sutton SW, Plotsky PM (1990). Glucocorticoid feedback inhibition of adrenocorticotro-pic hormone secretagogue release.Relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology 51: 328-336.
39. Sarnyai Z, McKittrick CR, McEwen BS, Kreek MJ (1998). Selective regulation of dopamine transporter binding in the shell of the nucleus accumbens by adrenalectomy and corticosterone-replacement. Synapse 30: 334-337.
40. Shaham Y, Erb S, Stewart J (2000). Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Rev 33: 13-33.
41. Sillaber I, Montkowski A, Landgraf R, Barden N, Holsboer F, Spanagel R (1998). Enhanced morphine-induced be-havioural effects and dopamine release in the nucleus accum-bens in a transgenic mouse model of impaired gluco-corticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide. Neuroscience 85: 415-425.
42. Spanagel B, Stohr T, Barden N, Holsboer F (1996). Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 8: 93-97.
43. Stec I, Barden N, Reul JM, Holsboer F (1994). Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res 28: 1-5.
44. Strohle A, Poettig M, Barden N, Holsboer F, Montkowski A (1998). Age- and stimulus-dependent changes in anxiety-related beha-viour of transgenic mice with GR dysfunction. Neuroreport 9: 2099-2102.
45. Sulzer D, Maidment NT, Rayport S (1993). Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60: 527-535.
46. Sulzer D, Rayport S (1990). Amphetamine and other psychosti-mulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5: 797-808.
47. Tanda G, Pontieri FE, Frau R, Di Chiara G (1997). Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9: 2077-2085.
48. Tremblay M, Rouillard C, Levesque D (1999). Dopamine D3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain. Synapse 32: 51-57.
49. Werme M, Olson L, Brene S (2000a). NGFI-B and Nor-1 mRNAs are upregulated in brain reward pathways by drugs of abuse: different effects in fischer and lewis rats. Mol Brain Res 76: 18-24.
50. Werme M, Ringholm A, Olson L, Brene S (2000b). Defferential patterns of induction of NGFI-B, Nor-1 and c-fos mRNAs in striatal subregions by haloperidol and clozapine. Brain Res 863: 112-119.
51. Wise RA, Bozarth MA (1987).A psychomotor stimulant theory of addiction. Psychol Rev 94: 469-492.
52. Yamamoto BK, Novotney S (1998). Regulation of extracellular dopamine by the norepinephrine transporter. J Neurochem 71: 274-280.
53. Young ST, Porrino LJ, Iadarola MJ (1991). Cocaine induces striatal c-fos -immunoreactive proteins via dopaminergic D-1 receptors. ProcNatlAcadSci USA 88: 1291-1295.
54. Zetterström RH, Williams R, Perlmann T, Olson L (1996). Cellular expression of the immediate early transcription factors Nurr1 and NGFI-B suggests a gene regulatory role in several brain regions including the nigrostriatal dopamine system. Mol Brain Res 41: 111-120.